Ocular Surface and Proteomic Safety Biomarkers in Topical Medication

Acta Ophthalmologica - United States
doi 10.1111/aos.13972_482
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review

Open Ophthalmology Journal
Ophthalmology
2014English

Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2015English

Ocular Surface Squamous Neoplasia Treated With Topical Interferon Α 2b

BMJ Case Reports
Medicine
2017English

New and Emerging Ocular Biomarkers

Acta Ophthalmologica
MedicineOphthalmology
2018English

Topical Interferon Alfa-2b for Management of Ocular Surface Squamous Neoplasia in 23 Cases

Archives of Ophthalmology
2012English

Medication Safety Beyond the Hospital and Role of Pharmacists in Ambulatory Medication Safety Process

Journal of Pharmacy Practice and Community Medicine
2017English

An Evaluation of the in Vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration Versus Oral Administration

Scientific Reports
Multidisciplinary
2017English

A Study of the Effects of Topical Timolol 0.5% and Bimatoprost 0.03% on the Ocular Surface

Journal of Evidence Based Medicine and Healthcare
2017English

Medication Safety in the Home

Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy